Deer­field backs $81M round for biotech de­vel­op­ing an­ti­fun­gal ther­a­py with less tox­i­c­i­ty

Elion Ther­a­peu­tics, a biotech fo­cused on in­va­sive fun­gal in­fec­tions, has raised $81 mil­lion in a Se­ries B fund­ing round for its ear­ly-stage can­di­date, it an­nounced …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.